Over the last decade, a significant amount of research has focused on the potential link between brain disorders and gut microbes. There is significant evidence that the gut microbiome plays a key role in identifying risk factors for several disorders, including:
However, interpreting this data can be challenging. This is because gut microbes are influenced by things such as exercise and diet. Additional research is still required, but the correlative relationship between brain disorders and gut microbes cannot be ignored.
Are Brain Disorders Caused by Gut Microbes?
Several trailblazers in the field have proposed that issues within the gut microbiome can trigger a variety of brain disorders. They have also hypothesized that gut microbes can influence the severity of these conditions. These presumptions are based on several animal-based studies. No meaningful human trials have been conducted at this point.
While no trials have been completed as of yet, scientists have gathered empirical data from patients suffering from certain neurodegenerative conditions. Their findings support the presumption that gut microbes can cause or worsen various brain disorders. They established a link between the presence of certain microbes and an increased risk of developing conditions such as ALS.
Can Brain Disorders Be Treated by Altering the Gut Microbe?
Unfortunately, research into the connection between the gut microbe and brain disorders has not given way to any new treatment options as of yet. Due to the nature of medical science, it will likely be several years before this data is translated into meaningful solutions.
Patients may explore to have a comprehensive evaluation on their overall and gut health with tests that can be done at home and sent to be evaluated. Learn your personal blueprint today with Genova Diagnostic testing available.
Others are discovering new neurodegeneration therapy opportunities that have arisen in recent years. The most notable of these is regenerative medicine, also known as stem cell therapy. This alternative option is available for access and initial research has resulted in showing potential outcomes in both symptom management and slowing condition progression.